- Home
- ESPR vs GCO Comparison
ESPR vs GCO Comparison
Compare ESPR & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- GCO
- Stock Information
- Founded
- ESPR 2008
- GCO 1924
- Country
- ESPR United States
- GCO United States
- Employees
- ESPR N/A
- GCO N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- ESPR Health Care
- GCO Consumer Discretionary
- Exchange
- ESPR Nasdaq
- GCO Nasdaq
- Market Cap
- ESPR 445.6M
- GCO 359.6M
- IPO Year
- ESPR 2013
- GCO N/A
- Fundamental
- Price
- ESPR $2.82
- GCO $32.71
- Analyst Decision
- ESPR Buy
- GCO Buy
- Analyst Count
- ESPR 6
- GCO 3
- Target Price
- ESPR $6.50
- GCO $32.67
- AVG Volume (30 Days)
- ESPR 6.1M
- GCO 233.9K
- Earning Date
- ESPR 11-06-2025
- GCO 08-28-2025
- Dividend Yield
- ESPR N/A
- GCO N/A
- EPS Growth
- ESPR N/A
- GCO N/A
- EPS
- ESPR N/A
- GCO N/A
- Revenue
- ESPR $268,125,000.00
- GCO $2,362,215,000.00
- Revenue This Year
- ESPR $10.59
- GCO $2.53
- Revenue Next Year
- ESPR N/A
- GCO $2.01
- P/E Ratio
- ESPR N/A
- GCO N/A
- Revenue Growth
- ESPR N/A
- GCO 2.66
- 52 Week Low
- ESPR $0.69
- GCO $16.19
- 52 Week High
- ESPR $3.94
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- ESPR 78.99
- GCO 60.81
- Support Level
- ESPR $2.37
- GCO $31.26
- Resistance Level
- ESPR $2.73
- GCO $33.86
- Average True Range (ATR)
- ESPR 0.16
- GCO 1.96
- MACD
- ESPR 0.02
- GCO -0.01
- Stochastic Oscillator
- ESPR 99.32
- GCO 72.27
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.